MedPath
HSA Approval

ALUMAG TABLETS

SIN03159P

ALUMAG TABLETS

ALUMAG TABLETS

June 8, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AD01

ordinary salt combinations

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

ALUMINIUM HYDROXIDE (DRIED GEL)

250 mg

Aluminum hydroxide

MAGNESIUM TRISILICATE

250 mg

Magnesium trisilicate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALUMAG TABLETS - HSA Approval | MedPath